A study that is expected to “open the door” to more adult-use cannabis trials in Switzerland and Europe is back on track after the second batch of cannabis was approved for use.
Pure Production AG confirmed that it had received approval from Swiss health authorities to supply the cannabis after its first 30-kilogram batch failed to meet quality standards.
The Weed Care pilot program was initially scheduled to launch in Switzerland’s third most populous city, Basel, on September 15th and was to run until March 2025
However, days before the start of regulated sales of adult-use cannabis at selected pharmacies in Basel, the city’s health department announced that the marijuana supplied “did not meet the quality standards set out in the pilot study regulation under the Narcotics Act.”
To read the complete article, go to www.born2invest.com